Research programme: non-coding RNA therapeutics - Heqet Therapeutics
Alternative Names: ncRNAs; non-coding-RNAsLatest Information Update: 05 Aug 2023
At a glance
- Originator Heqet Therapeutics
- Class Anti-ischaemics; Untranslated RNA
- Mechanism of Action RNA interference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Myocardial infarction